79 related articles for article (PubMed ID: 20124604)
1. Expression changes of serotonin receptor gene subtype 5HT3a in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and Olanzapin.
Shariati GR; Ahangari G; Hossein-nezhad A; Asadi SM; Pooyafard F; Ahmadkhaniha HR
Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):135-9. PubMed ID: 20124604
[TBL] [Abstract][Full Text] [Related]
2. Significant changes of 5-Hydroxytriptamine 3A receptor gene expression in peripheral blood mononuclear cells of allergic asthmatic patients.
Mohammadi Amirabad L; Ahangari G; Derakhshan Deilami G
Iran J Allergy Asthma Immunol; 2014 Feb; 13(1):33-9. PubMed ID: 24338226
[TBL] [Abstract][Full Text] [Related]
3. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines.
Taraskina AE; Nasyrova RF; Zabotina AM; Sosin DN; Sosina КА; Ershov EE; Grunina MN; Krupitsky EM
BMC Psychiatry; 2017 Dec; 17(1):394. PubMed ID: 29221470
[TBL] [Abstract][Full Text] [Related]
4. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J
Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
[TBL] [Abstract][Full Text] [Related]
6. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
[TBL] [Abstract][Full Text] [Related]
7. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.
Gomez JC; Crawford AM
J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine and haloperidol for residual symptoms.
de Haan L; van Beveren N
Am J Psychiatry; 2005 Jul; 162(7):1392-3; author reply 1393. PubMed ID: 15994737
[No Abstract] [Full Text] [Related]
9. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
10. [The effect of antipsychotic drug on monoamine receptors in peripheral blood mononuclear cells: affinity linked mechanism].
Taraskina AE; Zabotina AM; Nasyrova RF; Sosin DN; Sosina KA; Ershov EE; Grunina MN; Krupitsky EM
Biomed Khim; 2018 Mar; 64(2):201-207. PubMed ID: 29723151
[TBL] [Abstract][Full Text] [Related]
11. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
Paquet F; Soucy JP; Stip E; Lévesque M; Elie A; Bédard MA
J Neuropsychiatry Clin Neurosci; 2004; 16(1):47-56. PubMed ID: 14990759
[TBL] [Abstract][Full Text] [Related]
12. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
[TBL] [Abstract][Full Text] [Related]
14. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
16. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drug effects on brain morphology in first-episode psychosis.
Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
[TBL] [Abstract][Full Text] [Related]
18. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study.
Zhang ZJ; Kang WH; Li Q; Wang XY; Yao SM; Ma AQ
Schizophr Res; 2006 Dec; 88(1-3):102-10. PubMed ID: 16959472
[TBL] [Abstract][Full Text] [Related]
20. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
